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a  b  s  t  r  a  c  t
Purpose:  Computed  tomography  (CT)  scans  are  an  important  source  of  ionizing  irradiation  (IR) in medicine
that can  induce  a  variety  of  DNA damage  in  human  tissues.  With  technological  improvements  CT  scans
at  reduced  absorbed  doses  became  feasible  presumably  lowering  genotoxic  side effects.
Materials  and methods:  For  measuring  DNA  damage  we  performed  H2AX  foci  microscopy  in peripheral
blood  mononuclear  cells  (PBMC)  after  exposure  to  reduced  and  conventional  absorbed  radiation  doses
using  3rd  generation  dual-source  CT  (DSCT)  technology.
Results: CT  scans  performed  at reduced  absorbed  doses  of  3 mGy  induced  signiﬁcant  lower  levels
(p  < 0.0001)  of DNA  damage  (0.05  focus  per  cell  ±  0.01  [mean  ± standard  error  of  mean])  at 5 min  after
IR  compared  to conventional  absorbed  doses  of  15 mGy  (0.30  focus  per  cell  ±  0.03).  With  ongoing  DNA
repair  background  H2AX  foci  levels  (0.05  focus  per cell)  were  approached  at 24 h  after  CT  with  both
protocols.
Conclusion:  Our  results  provide  evidence  that  reduced  absorbed  doses  mediated  by  adjusted  tube current
in 3rd  generation  DSCT  induce  lower  levels  of  DNA  damage  in PBMC  compared  to conventional  absorbed
doses  suggesting  a  lower  genotoxic  risk  for state-of-the-art  tube  current  reduced  CT  protocols.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
With increased availability of multi-detector row computed
omography (CT), the use of CT examinations increased rapidly in
ll age groups in the last decade [1,2]. In parallel, radiation expo-
ure and the resulting biologic effects became topics of ongoing
iscussion [3]. Although the risk for induction of cancer by a single
T scan is low (about 1:2000 assuming an effective dose of 10 mSv
er scan) [4], it may  translate into a considerable number of cancer
ases in an epidemiologic scale [5]. In addition to theoretical risk
alculations two large prospective cohort studies from the UK and
ustralia provided evidence for a signiﬁcant increased cancer risk
n individuals exposed to CT scans in childhood and adolescence
6,7]. Furthermore, the risk is also increased in individuals under-
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going repeated CT scans, which is often required in cancer patients
for adequate treatment planning and follow-up, so that individ-
ual cumulative radiation doses may  exceed >300 mSv  [8]. Thus,
radiologists, physicists and CT scanner manufacturers seek to keep
radiation exposure by CT scans “as low as reasonably achievable”
(ALARA principle). Importantly, advances in CT hard- and software
including automatic tube voltage selection, automatic tube current
selection and iterative image reconstruction (e.g., provided by 3rd
generation dual-source CT (DSCT)) allow now for reduction of the
applied irradiation (IR) dose and thereby potentially lower geno-
toxic side effects.
Generally, for dose measurements conventional dosimeters
such as ionization chambers are widely-used as they deliver fast
and exact dose readings. However, for monitoring biological effects
of IR, methods assaying speciﬁc molecular changes might be more
appropriate. Since many years cytogenetic analysis of dicentric
chromosomes has been the gold standard for biological dosime-
try, however, sensitivity of this assay is limited to doses >100 mGy
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
























































Fig. 1. Linear dose dependency of H2AX foci formation in peripheral blood
mononuclear cells (PBMC) after irradiation. PBMC samples were irradiated each
with doses of 3 mGy, 15 mGy and 50 mGy  by a 3rd generation dual-source CT. Each
data point represents the mean H2AX foci yield ± standard error of the mean ofH.D. Popp et al. / European Journa
9]. For monitoring DNA damage at lower doses >1 mGy, H2AX
mmunoﬂuorescence microscopy has evolved as a more sensitive
nd appropriate method in recent years. This assay relies on detec-
ion of the Ser139-phosphorylated form of histone H2AX (also
amed H2AX), that accumulates in a region of several megabase
airs around each DNA double-strand break (DSB) [10]. There, mul-
iple H2AX histones form a platform for other proteins involved
n DNA repair, chromatin remodeling and signal transduction [11].
H2AX foci emerge rapidly after exposure to IR in the nucleus and
sability of this assay for monitoring formation and repair of DSB
fter CT has been demonstrated previously [12–15].
The hypothesis of our study was that lower radiation dose
evels, that became clinically feasible with state-of-the-art CT tech-
ologies, directly translate into less measurable DNA damage.
herefore, we prospectively compared H2AX immunoﬂuores-
ence microscopy based DNA damage measurements in peripheral
lood mononuclear cells (PBMC) between a conventional radiation
ose as well as a radiation dose reduced CT protocol.
. Materials and methods
.1. Peripheral blood samples
After institutional review board approval (Ethics Committee II,
edical Faculty Mannheim, University of Heidelberg) and written
nformed consent were obtained, peripheral blood samples were
ithdrawn from 12 healthy volunteers (5 male, 7 female, mean
ge: 39.3 years, range 25 to 55). PBMC were isolated by Ficoll den-
ity gradient centrifugation and cultivated in RPMI-1640 medium
upplemented with 10% fetal calf serum, 4 mM glutamine and 1%
enicillin/streptomycin. Cells were incubated in a humidiﬁed 5%
O2 atmosphere at 37 ◦C until exposure to IR by CT.
.2. In vitro x-ray irradiation
All PBMC samples were scanned in ﬂasks using a 3rd generation
SCT (SOMATOM Force, Siemens Healthcare Sector, Forchheim,
ermany). The following imaging parameters were used: 120 kV,
ffective tube time-current 45 mAs  (absorbed doses of 3 mGy),
24 mAs  (absorbed doses of 15 mGy) and 746 mAs  (absorbed doses
f 50 mGy). A rotation time of 0.5 s, a pitch of 35, a collimation of
 × 198 × 0.6 mm and a scan length of 12 cm were chosen and kept
onstant for each scan. All samples were positioned in the isocenter
f the CT scanner in order to guarantee same IR for each sample.
fter IR samples were incubated again in a humidiﬁed 5% CO2 atmo-
phere at 37 ◦C until analysis of H2AX foci at indicated time points.
ll 12 PBMC samples from 12 healthy volunteers were analyzed for
H2AX foci yields at 5 min  and 24 h after CT with doses of 3 mGy
nd 15 mGy, respectively. In 12 PBMC samples H2AX foci yields
ere also analyzed at 5 min  after CT with a dose of 50 mGy  for deter-
ination of dose dependence of H2AX foci formation. In three of
2 PBMC samples H2AX foci yields were additionally analyzed at
0 min  and 5 h after CT with doses of 3 mGy, 15 mGy  and 50 mGy,
espectively, for determination of DNA repair kinetics.
.3. Sample processing and H2AX immunoﬂuorescence staining
PBMC were cytospun (1000 rpm) on glass slides, ﬁxed in
araformaldehyde 4% (10 min) and permeabilized by Triton-X-
00 0.1% (10 min). Samples were incubated with a primary mouse
onoclonal anti-H2AX antibody (1:500) (clone JBW301; Merck
illipore, Darmstadt, Germany) overnight at 4 ◦C. After washing in
BS and blocking in Chemiblocker (Merck Millipore) PBMC were
ncubated with an Alexa Fluor 488-conjugated goat anti-mouse
econdary antibody (1:500) (Invitrogen, Karlsruhe, Germany) for
 h at room temperature. PBMC were washed again and mounted12  different PBMC samples at 5 min  after irradiation exposure. Mean H2AX foci
yields are corrected by subtracting the mean H2AX foci yield of the background
(0.05 focus per cell).
with Vectashield mounting medium containing 4,6-diamidino-2-
phenylindole (Vector Laboratories, Burlingame, US). Images were
obtained by an Axioscope A1 ﬂuorescence microscope (Zeiss, Jena,
Germany) equipped with a Cool Cube 1 CCD camera (Metasystems,
Altlussheim, Germany) and processed by Isis software (Metasys-
tems). Foci analysis was  performed by eye during imaging at a 100×
objective magniﬁcation. At least 100 typical lymphocytic cells were
analyzed for each measurement.
2.4. Statistical analysis
Statistical analysis was performed using SAS 9.3 (SAS Insti-
tute Inc., Cary, US). The paired sample t-test was used to test the
hypotheses whether there is a signiﬁcant difference in H2AX foci
yields after absorbed doses of 15 mGy  and 3 mGy  at 5 min  after
CT and whether there is no signiﬁcant difference at 24 h after CT.
P-values <0.05 were considered as statistically signiﬁcant.
3. Results
3.1. Validation of H2AX foci formation in irradiated PBMC
in vitro
H2AX foci yields were analyzed in PBMC at a dose range from
0 to 50 mGy. H2AX foci yields increased linearly with dose and
the mean increment of H2AX foci was  1.14 foci per cell at 50 mGy
(Fig. 1). A mean background level of 0.05 H2AX focus per cell was
detected in non-irradiated PBMC.
3.2. DNA repair kinetics in PBMC in vitro after IR by CT
DNA repair kinetics were analyzed in three samples of PBMC in
a time interval from 0 to 24 h after exposure to IR by CT at absorbed
doses of 3 mGy, 15 mGy  and 50 mGy, respectively. After induction
of DSB by IR, H2AX foci reached maximum foci yields at 5 min
followed by a non-linear biphasic decline with a fast repair com-
ponent until 5 h and a slow repair component until 24 h after IR
(Fig. 2).
3.3. Formation of H2AX foci in PBMC in vitro after protocols
with low absorbed and conventional absorbed doses12 samples of PBMC from 12 healthy volunteers were scanned
separately using protocols with absorbed doses of 3 mGy and
15 mGy. DNA damage was analyzed by H2AX foci microscopy
(Fig. 3) at 5 min  and 24 h after IR. The mean increment of H2AX foci
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Fig. 2. Repair kinetics of DNA double-strand breaks in peripheral blood mononu-
clear cells (PBMC) after irradiation. PBMC samples were irradiated each with doses
of  3 mGy, 15 mGy  and 50 mGy  by a 3rd generation dual-source CT and analyzed for




























Fig. 4. H2AX foci yields in peripheral blood mononuclear cells (PBMC) after apply-
ing reduced and conventional absorbed doses. Bars represent mean H2AX foci
yields ± standard errors of the mean of 12 different PBMC samples at 5 min  and 24 h
after application of reduced (3 mGy) and conventional absorbed doses (15 mGy)
F
(
bepresent the mean H2AX foci yields ± standard errors of the mean of three differ-
nt PBMC samples. Mean H2AX foci yields are corrected by subtracting the mean
H2AX foci yield of the background (0.05 focus per cell).
ields in PBMC was signiﬁcantly lower (p < 0.0001; 95% conﬁdence
nterval: 0.1988, 0.3162) for absorbed doses of 3 mGy  (0.05 focus
er cell ± 0.01 [mean ± standard error of mean]) compared to con-
entional absorbed doses of 15 mGy  (0.30 focus per cell ± 0.03) at
 min  after IR. No signiﬁcant difference (p = 0.8837; 95% conﬁdence
nterval: – 0.0131, 0.0114) in H2AX foci yields was detected at
4 h after IR (Fig. 4).
. Discussion
The clinical beneﬁt of CT examinations certainly outweighs
otential radiation-associated risks of CT by far. However, with con-
inuous increase of millions of CT scans performed annually, the
LARA principle should be kept in mind as small risks may  trans-
ate into a considerable number of cancer cases in the epidemiologic
cale. Moreover, the risk is also increased in patients undergo-
ng several CT examinations. In order to minimize IR-related risks,
everal dose saving techniques have been introduced throughout
he last years. For example, modern CT scanners (e.g., 3rd gener-
tion DSCT) automatically select tube voltage and modulate tube
urrent according to the patients´ topogram resulting in radiation
ose savings of up to 52% [16,17]. Further, high-pitch acquisitions
ave become an implement into routine CT protocols leading to
igher temporal resolution and to reduction of the applied radi-
tion dose down to a volume computed tomography dose index
CTDIvol) of 1.8 mGy  [17,18]. In addition, recent advances in itera-
ive image reconstruction, especially with the new model-based
ig. 3. Fluorescence microscopic images of H2AX foci in peripheral blood mononuclear c
blue,  DAPI) of PBMC at 5 min  after irradiation by a 3rd generation dual-source CT using
ars  5 m).using a 3rd generation dual-source CT. Mean H2AX foci yields are corrected by
subtracting the mean H2AX foci yield of the background (0.05 focus per cell).
iterative algorithms, allow for reduction of image noise, when
compared to traditional ﬁltered back projection, thus allowing for
signiﬁcantly lower IR doses [19,20]. When combining these new
techniques CTDIvol ranges between 1.7–12.4 mGy  can be achieved
depending on the tube voltage chosen and the scanned region
[16,19,20]. Hence, with technical advances (e.g., provided by 3rd
generation DSCT technology) it is now possible to signiﬁcantly
reduce absorbed doses and probably DNA-damage in affected tis-
sues. However, one has to be aware, that biological effects of IR can
be inﬂuenced by unapparent factors, as has been shown for appli-
cation of iodinated contrast agents that amplify CT-induced DNA
damage [21,22].
For quantiﬁcation of IR-induced DNA damage in PBMC after
3rd generation DSCT, we  performed H2AX immunoﬂuorescence
microscopy. DNA damage in PBMC was  signiﬁcantly reduced at
5 min  after IR when using minimum absorbed doses (3 mGy) com-
pared to conventional absorbed doses (15 mGy). Excess of H2AX
foci yields was linearly dose-dependent as published in previous
studies determining H2AX foci yields in cell cultures and lym-
phocytes after IR by IR devices in vitro or in lymphocytes after
conventional CT and angiography in vivo [13,15,23–26]. Further-
more, kinetics of H2AX foci formation and loss in PBMC from 0
to 24 h after IR in our experiments were comparable to results of
previous studies [12,24]. In addition, we observed approximation
of H2AX foci yields to background levels in PBMC at 24 h after IR
in vitro. Noteworthy, no signiﬁcant difference in H2AX foci yields
was observed in our experiments in PBMC at 24 h after reduced
absorbed doses of 3 mGy  when compared to conventional absorbed
doses of 15 mGy. However, a higher rate of acquired mutations in
ells (PBMC) after irradiation. Images show H2AX foci (green, Alexa 488) and nuclei
























































homologous recombination repair: implications for the formation of
chromosome translocations, Mutat. Res. Genet. Toxicol. Environ. Mutagen.
793 (2015) 166–175.H.D. Popp et al. / European Journa
BMC is still probable after conventional absorbed doses owing to a
igher burden of induced DNA damage, which is repaired by poten-
ially error-prone DNA repair mechanisms (e.g., repair of DSB by
lassical and alternative non-homologous end joining mechanisms)
27,28]. Conversely, reduced absorbed doses induce signiﬁcantly
ess DNA damage and are therefore probably associated with lower
ates of acquired mutations.
Models for risk estimation of CT are based on the so-called linear
o-threshold theory (LNT), which holds, that even exposure to low
oses of IR is associated with an excess of cancer risk proportional to
ose. The LNT is of considerable controversy because of extrapolat-
ng risks at intermediate doses (>100 mGy) down to lower doses
<100 mGy). In addition, the model of a linear dose response is
hallenged by potentially disturbing mechanisms (e.g., adaptive
esponse to ionizing radiation, apoptosis, bystander effect). How-
ver, no deviations from a linear dose effect should currently be
onsidered in the absence of convincing data [29]. Thus, even very
ow radiation doses as feasible by novel CT technologies are pre-
umably associated with a low theoretical risk.
Our study has limitations that need to be addressed e.g., exper-
ments were performed with PBMC in vitro and warrant validation
y investigations in vivo. Furthermore, variations in H2AX foci
ields and DNA repair kinetics may  occur when DNA damage is
nalyzed in different tissues of patients exposed to 3rd generation
SCT in the clinical setting.
In conclusion, imaging at reduced absorbed doses is now feasible
ith the latest technical innovations and holds broad implica-
ions for human health care. Importantly, protocols using reduced
bsorbed doses induce less DNA damage in comparison to protocols
sing conventional absorbed doses suggesting a lower genotoxic
isk for individuals undergoing CT examinations.
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